Alimera Sciences, Inc. is a commercial-stage global pharmaceutical company. The Company is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for no... Read more
Yahoo
Yahoo
MarketWatch
Yahoo
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.